DaVita HealthCare Partners’ (DVA) “Hold” Rating Reiterated at RBC Capital Markets

DaVita HealthCare Partners Inc. (NYSE:DVA)‘s stock had its “hold” rating reissued by equities researchers at RBC Capital Markets in a report issued on Friday. They currently have a $62.00 target price on the stock. RBC Capital Markets’ price objective would indicate a potential downside of 4.11% from the stock’s current price.

A number of other research analysts have also commented on DVA. Wells Fargo & Company reaffirmed an “outperform” rating on shares of DaVita HealthCare Partners in a research report on Tuesday, November 1st. Zacks Investment Research raised shares of DaVita HealthCare Partners from a “strong sell” rating to a “hold” rating in a research report on Friday, November 4th. Jefferies Group LLC reissued a “buy” rating and issued a $70.00 price target (down previously from $86.00) on shares of DaVita HealthCare Partners in a research report on Saturday, November 19th. Bank of America Corporation reissued a “hold” rating and issued a $68.00 price target on shares of DaVita HealthCare Partners in a research report on Monday, November 21st. Finally, Robert W. Baird lowered shares of DaVita HealthCare Partners from an “outperform” rating to a “neutral” rating and increased their price target for the stock from $68.00 to $69.00 in a research report on Tuesday, December 13th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the stock. DaVita HealthCare Partners has an average rating of “Hold” and an average target price of $72.00.

Analyst Recommendations for DaVita HealthCare Partners (NYSE:DVA)

Shares of DaVita HealthCare Partners (NYSE:DVA) traded up 4.70% during trading on Friday, hitting $67.70. The stock had a trading volume of 1,241,970 shares. The stock’s 50-day moving average price is $64.32 and its 200 day moving average price is $64.30. DaVita HealthCare Partners has a one year low of $54.50 and a one year high of $78.77. The stock has a market cap of $13.36 billion, a price-to-earnings ratio of 19.73 and a beta of 1.02.

DaVita HealthCare Partners (NYSE:DVA) last announced its quarterly earnings data on Thursday, February 16th. The company reported $0.98 EPS for the quarter, beating the Zacks’ consensus estimate of $0.91 by $0.07. The business earned $3.72 billion during the quarter, compared to analyst estimates of $3.74 billion. DaVita HealthCare Partners had a net margin of 4.92% and a return on equity of 16.16%. The firm’s revenue for the quarter was up 5.2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.12 earnings per share. On average, equities analysts forecast that DaVita HealthCare Partners will post $3.76 EPS for the current year.

This story was first posted by WKRB News and is the property of of WKRB News. If you are reading this story on another publication, it was stolen and republished in violation of US and international trademark and copyright legislation. The original version of this story can be accessed at http://www.wkrb13.com/markets/1981493/davita-healthcare-partners-dva-hold-rating-reiterated-at-rbc-capital-markets.html.

Several hedge funds have recently bought and sold shares of the company. Cacti Asset Management LLC raised its stake in DaVita HealthCare Partners by 6.3% in the third quarter. Cacti Asset Management LLC now owns 4,305 shares of the company’s stock valued at $280,000 after buying an additional 255 shares during the last quarter. Financial Engines Advisors L.L.C. raised its stake in DaVita HealthCare Partners by 22.3% in the second quarter. Financial Engines Advisors L.L.C. now owns 36,142 shares of the company’s stock valued at $2,794,000 after buying an additional 6,579 shares during the last quarter. Hikari Power Ltd raised its stake in DaVita HealthCare Partners by 5.6% in the third quarter. Hikari Power Ltd now owns 288,900 shares of the company’s stock valued at $19,088,000 after buying an additional 15,400 shares during the last quarter. Emerald Acquisition Ltd. raised its stake in DaVita HealthCare Partners by 18.6% in the third quarter. Emerald Acquisition Ltd. now owns 175,369 shares of the company’s stock valued at $11,587,000 after buying an additional 27,490 shares during the last quarter. Finally, Canada Pension Plan Investment Board raised its stake in DaVita HealthCare Partners by 236.2% in the third quarter. Canada Pension Plan Investment Board now owns 295,970 shares of the company’s stock valued at $19,555,000 after buying an additional 207,944 shares during the last quarter. 85.31% of the stock is owned by institutional investors.

About DaVita HealthCare Partners

DaVita Inc, formerly DaVita HealthCare Partners Inc, is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company’s segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives.

5 Day Chart for NYSE:DVA

This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/1981493/davita-healthcare-partners-dva-hold-rating-reiterated-at-rbc-capital-markets.html

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.